Rankings
▼
Calendar
SRPT Q4 2024 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$658M
+65.9% YoY
Gross Profit
$526M
79.9% margin
Operating Income
$162M
24.6% margin
Net Income
$159M
24.2% margin
EPS (Diluted)
$1.50
QoQ Revenue Growth
+40.9%
Cash Flow
Operating Cash Flow
$92M
Free Cash Flow
$54M
Stock-Based Comp.
$50M
Balance Sheet
Total Assets
$4.0B
Total Liabilities
$2.4B
Stockholders' Equity
$1.5B
Cash & Equivalents
$1.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$658M
$397M
+65.9%
Gross Profit
$526M
$353M
+49.2%
Operating Income
$162M
$25M
+556.6%
Net Income
$159M
$46M
+248.4%
Geographic Segments
UNITED STATES
$420M
85%
Rest of World
$76M
15%
← FY 2024
All Quarters
Q1 2025 →